These aggregate findings underscore the importance of CHF1/Hey2 in cardiac hypertrophy, and suggest that future therapies based on CHF1/Hey2 may have important therapeutic implications in preventing hypertrophy and heart failure. Here, HEY2 is linked to cardiac hypertrophy.